Differentiating Pathology of Acute Disseminated Encephalomyelitis From Multiple Sclerosis in Children Using Diffusion

Esra Pehlivan1, Martin Kinuthia Mwangi2, Vihas Abraham1

  • 1Division of Pediatric and Developmental Neurology, Department of Neurology, Washington University in St. Louis, St. Louis, Missouri.

Pediatric Neurology
|March 21, 2025
PubMed

Insights

Diffusion Basis Spectrum Imaging (DBSI) reveals distinct white matter differences in pediatric-onset multiple sclerosis (POMS) compared to acute disseminated encephalomyelitis (ADEM), highlighting axonal injury and demyelination in POMS.

Area of Science:

  • Neuroimaging
  • Pediatric Neurology
  • Radiology

Background:

  • Pediatric-onset multiple sclerosis (POMS) and acute disseminated encephalomyelitis (ADEM) are distinct neurological conditions in children.
  • Differentiating POMS and ADEM is crucial for appropriate treatment and prognosis.
  • Advanced neuroimaging techniques are needed to elucidate underlying pathologic differences.

Purpose of the Study:

  • To investigate the pathologic differences between POMS and ADEM using Diffusion Tensor Imaging (DTI) and Diffusion Basis Spectrum Imaging (DBSI).
  • To compare DTI and DBSI diffusivity measures in pediatric patients diagnosed with POMS and ADEM.

Main Methods:

  • Fifteen children with POMS and eight with ADEM underwent both DTI and DBSI scans.
  • Group comparisons and longitudinal associations of DTI and DBSI measures were analyzed.
  • Statistical analysis focused on diffusivity measures over time.

Main Results:

  • DBSI revealed significant differences between POMS and ADEM, with lower fractional anisotropy in POMS indicating axonal injury.
  • POMS showed higher DBSI fiber fraction and radial diffusivity, suggesting demyelination and higher axonal density.
  • No significant differences in DTI measures were observed between POMS and ADEM over time.

Conclusions:

  • DBSI is a valuable tool for quantitatively assessing axonal injury, demyelination, and inflammation in pediatric CNS white matter diseases.
  • DBSI offers advantages over DTI in differentiating POMS and ADEM.
  • Larger prospective studies are needed to validate these findings.
Abstract